ATA498379A - Verfahren zur herstellung von n-cyano-n'-methyl-n''-(2-((5-methylimidazol-4-y )-methyl)-thioaethyl) -guanidin - Google Patents

Verfahren zur herstellung von n-cyano-n'-methyl-n''-(2-((5-methylimidazol-4-y )-methyl)-thioaethyl) -guanidin

Info

Publication number
ATA498379A
ATA498379A AT0498379A AT498379A ATA498379A AT A498379 A ATA498379 A AT A498379A AT 0498379 A AT0498379 A AT 0498379A AT 498379 A AT498379 A AT 498379A AT A498379 A ATA498379 A AT A498379A
Authority
AT
Austria
Prior art keywords
methyl
thioaethyl
methylimidazol
guanidine
cyano
Prior art date
Application number
AT0498379A
Other languages
English (en)
Other versions
AT366033B (de
Inventor
Zdravko Dr Ing Crnic
Gordana Dr Ing Karlovic
Gorjana Dipl Ing Radobolja
Slobodan Dr Ing Djorkic
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of ATA498379A publication Critical patent/ATA498379A/de
Application granted granted Critical
Publication of AT366033B publication Critical patent/AT366033B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT0498379A 1978-07-19 1979-07-19 Verfahren zur herstellung von n-cyano-n'-methyl-n"-(2-((5-methylimidazol-4-yl -methyl)-thioaethyl) -guanidin AT366033B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU1725/78A YU40716B (en) 1978-07-19 1978-07-19 Process for obtaining n-cyano-n'-methyl-n'-û2-|5-metylimidazole4-yl)-methyl¨-thioethylù guanidine

Publications (2)

Publication Number Publication Date
ATA498379A true ATA498379A (de) 1981-07-15
AT366033B AT366033B (de) 1982-03-10

Family

ID=25555343

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0498379A AT366033B (de) 1978-07-19 1979-07-19 Verfahren zur herstellung von n-cyano-n'-methyl-n"-(2-((5-methylimidazol-4-yl -methyl)-thioaethyl) -guanidin

Country Status (7)

Country Link
AT (1) AT366033B (de)
CH (1) CH643246A5 (de)
DE (1) DE2928857B2 (de)
GB (1) GB2025969B (de)
IT (1) IT1121013B (de)
SU (1) SU886744A3 (de)
YU (1) YU40716B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185298B (en) * 1981-06-26 1984-12-28 Richter Gedeon Vegyeszet Process for producing cimetidine
HU185636B (en) * 1981-06-26 1985-03-28 Richter Gedeon Vegyeszet Process for preparing new cimetidine-hydrate /cimetidine-h/
MY100734A (en) * 1986-09-01 1991-01-31 Mitsui Petrochemical Ind Process for preparation of guanidine derivative.
JPH0629234B2 (ja) * 1986-12-26 1994-04-20 三井石油化学工業株式会社 α−アシロキシケトン誘導体
US5808090A (en) * 1996-02-22 1998-09-15 Endo Pharmaceuticals Inc. Process for preventing precipitation in cimetidine injection solutions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1531221A (en) 1974-09-02 1978-11-08 Smith Kline French Lab Process for preparing guanidine derivatives
GB1533380A (en) 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines

Also Published As

Publication number Publication date
IT7968506A0 (it) 1979-07-19
YU40716B (en) 1986-04-30
DE2928857A1 (de) 1980-02-07
IT1121013B (it) 1986-03-26
GB2025969A (en) 1980-01-30
GB2025969B (en) 1982-09-02
SU886744A3 (ru) 1981-11-30
DE2928857B2 (de) 1981-07-23
CH643246A5 (de) 1984-05-30
AT366033B (de) 1982-03-10
DE2928857C3 (de) 1988-02-11
YU172578A (en) 1982-10-31

Similar Documents

Publication Publication Date Title
ATA469882A (de) Verfahren zur herstellung von neuen 2-(4-(4,4dialkyl-2,6-piperidin-dion-1-yl)-butyl)-1piperazinyl))-pyrimidinen
AT366034B (de) Verfahren zur herstellung von neuen 5-substituier-ten hydantoinen
AT362777B (de) Verfahren zur herstellung von 4-(6'-methoxy-2'naphthyl)-butan-2-on
AT383807B (de) Verfahren zur herstellung von neuen 7beta-(fluoriertes methylthio)-acetamido-7alphamethoxy-3-(1-(2-hydroxyalkyl)-1h-tetrazol-5-yl)
AT366699B (de) Verfahren zur herstellung von 3'', 4''-diacyltylosinderivaten
AT363955B (de) Verfahren zur herstellung von n-cyano-n'-(2-((4 -methyl-5-imidazolyl)methylthio)aethyl)-n''-alkinylguanidinen
ATA498379A (de) Verfahren zur herstellung von n-cyano-n'-methyl-n''-(2-((5-methylimidazol-4-y )-methyl)-thioaethyl) -guanidin
AT367739B (de) Verfahren zur herstellung von 2',6'-dialkyl-n(alkoxymethyl)-2-chloracetaniliden
AT371482B (de) Verfahren zur herstellung von neuen 4-(substituierten) thio-1-b-d-
ATA19580A (de) Verfahren zur herstellung von blutdrucksenkendem 6,7-dimethoxy-4-amino-2-(4-(2-furoly)-1piperazinyl) chinazolinhydrochlorid
AT367026B (de) Verfahren zur herstellung von 2-(2-hydroxyaethoxy) aethyl-n-(alpha,alpha,alpha-trifluor-m-tolyl) anthranilat
AT368991B (de) Verfahren zur herstellung von n-cyano-n'-methyln''-(2-mercapto[thyl)-guanidin
ATA558379A (de) Verfahren zur herstellung von neuen 5-niedrigalkaly-2'-desoxyuridin-5'-monopsosphaten
AT374203B (de) Verfahren zur herstellung von neuen 2'-desoxy-3', 5'-di-o-alkylcarbonyl-5-fluoruridinderivaten
AT361910B (de) Verfahren zur herstellung von neuen 2,4- dichlorphenyl-imidazolyl-aethanonen(olen) sowie von deren salzen
ATA725277A (de) Verfahren zur herstellung von 1-(2'-furanidyl)- 5-fluoruracil
AT373593B (de) Verfahren zur herstellung von 1,2,3-thiadiazol-5- yl-harnstoffen
AT366052B (de) Verfahren zur herstellung von 4'-nitrobenzyl-7
AT378182B (de) Verfahren zur herstellung von 4-methoxy-2'-(2-(1-methyl-2-piperidyl)aethyl)benzanilid
ATA305683A (de) Verfahren zur herstellung von neuen n-(3-dimethylamino-2-(4-pyridinyl)-2-propenylid n)-n-methylmethan
AT353771B (de) Verfahren zur herstellung von neuen 2-(2',2'- dihalogenvinyl)-oder(2',2',2'-trihalogenaethyl)- cyclobutanonen
AT374195B (de) Verfahren zur herstellung von 2-(2-thenoylthio) -propionylglycin
AT384423B (de) Verfahren zur herstellung von 2-(e)-phenylmethylen-cycloheptan-1-on-(e)-oxim
AT366035B (de) Verfahren zur herstellung von neuen 5-substituier-ten hydantoinen
AT381309B (de) Verfahren zur herstellung von 5z-formen von 2,3,4 -trinor-1,5-inter-m-phenylen-prostacyclinderiva en

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee